Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2004-03-11
2008-08-05
Yu, Misook (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
Reexamination Certificate
active
07407762
ABSTRACT:
The present invention provides a method for detecting cancer in a patient. A sample from the patient is provided, and the level of oviduct-specific glycoprotein (OGP) in the sample is determined and compared to a control sample. Increased levels of OGP in the sample as compared to the control indicates that the patient has cancer. In one aspect, the cancer is a gynecological cancer, such as ovarian cancer. Kits for conducting the methods of the invention are also provided.
REFERENCES:
patent: WO 02/086443 (2002-10-01), None
patent: WO02/086443 (2002-10-01), None
Tockman et al (Cancer Res., 1992, 52:2711s-2718s).
O'Day-Bowman et al (Biology of Reproduction, Jan. 1996, 54:60-69).
Ogawa et al (American Journal of Pathology, Oct. 1999, 155(4):1047-1050).
Rustin et al (Annals of Oncology, Apr. 1996, 7:361-364).
Klug et al (Cancer Research, Mar. 1984, 44:1048-1053).
Arias et al. (Arias EB et al., Biol. Reprod. 51, pp. 685-694 (1994)).
Klug et al (Cancer Reasearch, Mar. 1984, 44: 1048-1053).
Rapisarda, John et al., Immunological characterization and immunocytochemical localization of an oviduct-specific glycoprotein in the human, Journal of Clinical Endocrinology and Metabolism, vol. 76, No. 6, 1993, pp. 1483-1488.
Miyoshi, Ichiro et al., Mouse transgenic for murine oviduct-specific glycoprotein promoter-driven simian virus 40 large T-antigen: Tumor formation and its hormonal regulation, Molecular Reproduction and Development, vol. 63, No. 2, Oct. 2002, pp. 168-176.
Lagow, Errin et al., Mammalian reproductive tract mucins, Human Reproduction Update, vol. 5, No. 4, Jul. 1999, pp. 280-292.
Buhi, William C., Characterization and biological roles of oviduct-specific, oestrogen-dependent glycoprotein, Reproduction, vol. 123, No. 3, Mar. 2002, pp. 355-362.
Mazurek, A et al., Clinical tumour markers in ovarian cancer, European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP), Feb. 1998, vol. 7, No. 1, Feb. 1998, pp. 23-25.
Bast, R.C. et al., CA 125: The past and the future, International Journal of Biological Markers, Wichtig Editore, Milan, IT, vol. 13, No. 4, Oct. 1998, pp. 179-187.
Hellstrom, Ingegerd et al., The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma, Cancer Research, vol. 63, No. 13, Jul. 1, 2003, pp. 3695-3700.
Woo, Michelle M.M. et al., Oviductal glycoprotein (OGP), a new differentiation-based indicator of ovarian and endometrial (pre)neoplastic changes, Proceedings of the American Association for Cancer Research Annual Meeting, vol. 44, Jul. 2003, p. 1343.
Woo, Michelle M.M. et al., Oviductal glycoprotein, a new differentiation-based indicator present in early ovarian epithelial neoplasia and cortical inclusion cysts, Gynecologic Oncology, vol. 93, No. 2, May 2004, pp. 315-319.
Auersperg Nelly
Gilks C. Blake
Woo Michelle
Aeder Sean
Bereskin & Parr
Gravelle Micheline
The University of British Columbia
Yu Misook
LandOfFree
Diagnosis of gynecological neoplasms by detecting the levels... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnosis of gynecological neoplasms by detecting the levels..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosis of gynecological neoplasms by detecting the levels... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3997200